EN | ES | DE | FR | IT | 日本語 | 한국어 | 中文

Protein Kinase Inhibitors: Inventing New Patent Strategies

Five Takeaways On New Cannabis Laws In Massachusetts
November 29, 2018
How to Allocate Resources to Intellectual Property as a Start-Up
January 11, 2019
Show all
 

 

 

Inventing New Patent Strategies:

Protein Kinase Inhibitors

 

By: Katie Rubino

 


 

Protein kinase inhibitors are the second most targeted group of drug targets, after G-protein coupled receptors, as the human body encodes over 500 protein kinases. Protein kinase inhibitors work by blocking the action of one or more protein kinases. Protein kinases are enzymes that add a PO4 phosphate group to an amino acid, generally serine, threonine, or tyrosine. Protein kinase inhibitors were first developed to treat cancer, which causes hyperactive protein kinases. By inhibiting overactive protein kinases, kinase inhibitors can regulate cell signaling pathways and stop uncontrolled cell growth and oncogenesis.

There are several different types of protein kinase inhibitors, classified based on the structure of the enzyme bound antagonist complex. The majority of inhibitors target the APT-site of the kinase in its active state. Type II inhibitors induce a distinguishable complex, as they occupy an additional hydrophobic pocket. Recently, naturally occurring kinase inhibitors have been discovered as a new class of kinase inhibitors, which can bind directly to tyrosine kinases to alter phosphorylation. Many of these naturally occurring kinase inhibitors have antioxidant properties and are sold on pharmacy shelves including resveratrol, quercetin, curcumin, and chrysin.

Protein kinase inhibitors were first discovered for the treatment of cancer in the late 1970’s and early 1980’s, when the first oncogene was fond to be a protein kinase. Following this discovery, the first protein kinase inhibitors, known as naphthalene sulphonamides were synthesized. This led to further research and development until the first protein kinase inhibitor was approved by the Food and Drug Administration (FDA) in 2001, known as imatinib or Gleevec. This medication is used to treat a number of cancers, such as for example chronic myeloid leukemia, gastrointestinal stromal tumors, acute lymphoblastic leukemia, as well as several others. Protein kinase inhibitors are ideal treatment options for patients diagnosed with cancer as they provide targeted therapy and limited toxicity, as compared to chemotherapy which can have a very narrow therapeutic index.

 

 

Currently, 37 kinase inhibitors have received FDA approval for different oncology-based indications, and over 150 kinase inhibitors are currently in clinical trials. Roughly 25% of all drug development is currently directed towards kinase inhibitors. Kinase inhibitors are being studied for many uses beyond oncology, including diseases such as liver ischemia, Crohn’s disease, osteoarthritis, and ischemia reperfusion. At the present moment, 2 kinase inhibitors have been approved for non-oncology-based treatments. These include Xeljanz approved for arthritis and Ofef approved for pulmonary fibrosis.

As kinase inhibitors have exhibited potentials far beyond oncology uses, the question remains, does a drug found to treat a new indication need a new patent? This is a complex problem, that can be traced back to aspirin.

Aspirin, also known as acetylsalicylic acid, was synthesized in 1899, and a patent was granted to Frederick Bayer & Company on March 6, 1899 for acetylsalicylic acid. Under the Patent Act of 1836, a patent filed in 1899 would have been valid for 14 years with an extension of up to an additional 7 years. However, patents for aspirin continued to be filed today. This is done through a process known as drug repositioning, whereby approved drugs and compounds are found to treat a different disease state. For example, Viagra was originally discovered to treat pulmonary hypertension, and only later on was it discovered to also be able to treat erectile dysfunction. Furthermore, the well-known antibiotic erythromycin used to treat bacterial infections of the skin and respiratory tract, was repositioned to treat a condition of delayed gastric emptying known as gastroparesis.

Through the process of drug repositioning, new methods of treatments are discovered and utilized. When a drug is first discovered for its initial use, a patent is generally obtained to cover the chemical compound, as well as patents that may cover methods of treating a disease state with the compound. After patents for the original compound have expired, new filings can be obtained by others pertaining to new methods of treatment or use that were not covered originally. For example, a search of recent aspirin filings shows patents obtained in the past five years showing unique methods for preparing aspirin, combining aspirin together in dosage forms with other medications, as well as stable aspirin preparations. These filings come almost 120 years after the original patent for acetylsalicylic aspirin was first obtained.

A review of patent filings at the United States Patent and Trademark Office (USPTO) indicates that the number of kinase inhibitor filings is on the rise. Since 2001, there have been 23,198 patents applications relating to kinase inhibitors filed at the USPTO. Over the past five years the number of patent applications filed relating to kinase inhibitors has continued to rise, with the exception of 2015. Furthermore, the number of patent applications filed relating to kinase inhibitors over the past 5 years accounts for 40% of all filings of patent applications relating to kinase inhibitors since 2001.  As of early December 2018, there have been 1,915 patent applications relating to kinase inhibitors filed. With still 1 more month to go before the close of this year, we can expect this number to continue to increase and quite possibly surpass last years filings.

 



As scientists continue to discover and explore drug discovery in this area, we can expect to see an increase in patent filings over the next few years. This may include new drugs that have been discovered, as well as old drugs that have been shown to do a new trick. Either way, as 2018 draws to a close, we can expect 2019 to be a year filled with exciting medical breakthroughs and innovation.

 


Ask a Question


 

20 Comments

  1. This is really interesting, You are a very skilled blogger.
    I’ve joined your rss feed and look forward to seeking more of your excellent post.
    Also, I’ve shared your website in my social networks!

  2. If some one desires to be updated with most recent technologies afterward he must be pay a visit this web
    page and be up to date every day.

  3. I truly love your site.. Pleasant colors & theme. Did you create this amazing site yourself?
    Please reply back as I’m trying to create my
    own site and want to find out where you got this from or exactly what the theme is named.
    Many thanks!

  4. Hey outstanding blog! Does running a blog such as this require a great
    deal of work? I have virtually no understanding of programming
    but I was hoping to start my own blog in the near future.
    Anyhow, if you have any ideas or tips for new blog owners please share.
    I know this is off topic however I just needed to ask.
    Cheers!

  5. This is a topic which is near to my heart… Best wishes!
    Exactly where are your contact details though?

  6. Pretty! This has been a really wonderful post. Thanks for
    supplying this info.

  7. Very good blog! Do you have any tips for
    aspiring writers? I’m planning to start my own blog soon but I’m a little lost on everything.
    Would you suggest starting with a free platform like WordPress or go for a paid option? There are so many choices
    out there that I’m totally overwhelmed .. Any recommendations?
    Thanks a lot!

  8. Hi there, I enjoy reading all of your post. I like to write a little comment to support you.

  9. I’m gone to tell my little brother, that he should also
    go to see this webpage on regular basis to take updated from most up-to-date news update.

  10. Hi, I desire to subscribe for this blog to take most
    up-to-date updates, so where can i do it please assist.

  11. Thanks a bunch for sharing this with all folks you actually
    realize what you’re talking about! Bookmarked. Please also seek advice from my web site =).
    We may have a hyperlink exchange agreement between us

  12. constantly i used to read smaller posts that as well clear their motive, and that is also happening with this paragraph which I am reading
    at this place.

  13. I was wondering if you ever thought of changing the structure
    of your site? Its very well written; I love what youve got to say.
    But maybe you could a little more in the way of content so
    people could connect with it better. Youve got an awful lot of text for only having 1 or 2 images.
    Maybe you could space it out better?

  14. tinyurl.com says:

    I like the helpful information you provide in your articles.
    I’ll bookmark your blog and check again here regularly. I am quite certain I will learn plenty of new
    stuff right here! Best of luck for the next!

  15. Hi there colleagues, how is the whole thing, and what you would like to say regarding this article,
    in my view its actually amazing designed for me.

  16. Hi, I do think your website might be having browser compatibility problems.
    Whenever I take a look at your site in Safari,
    it looks fine but when opening in Internet Explorer,
    it has some overlapping issues. I simply wanted
    to give you a quick heads up! Other than that, excellent site!

  17. tinyurl.com says:

    Hi there! Quick question that’s entirely off topic.
    Do you know how to make your site mobile
    friendly? My blog looks weird when viewing from my iphone.
    I’m trying to find a theme or plugin that might be
    able to resolve this problem. If you have any recommendations, please share.

    Cheers!

  18. Hi there everyone, it’s my first go to see at this website,
    and post is really fruitful for me, keep up
    posting these articles.

  19. “Very neat post.Really looking forward to read more. Keep writing.”

  20. tinyurl.com says:

    magnificent points altogether, you simply received a
    new reader. What would you recommend about your put up that you simply made a few days ago?
    Any positive?

Leave a Reply

Your email address will not be published. Required fields are marked *